Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib
about
Efficacy of physical therapy for the treatment of lateral epicondylitis: a meta-analysis.Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjectsLong-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis.The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis.Celecoxib for osteoarthritis.Lumiracoxib in the management of osteoarthritis and acute pain.First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis.Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis.Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trialsEfficacy of lumiracoxib in osteoarthritis: a review of nine studies.Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials.The safety of lumiracoxib when used in the treatment of arthritis.A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journalsClinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor.Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials.Cardiovascular risks of cyclooxygenase inhibition.Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritisComparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic reviewChondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled TrialsEfficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses.Efficacy of etoricoxib, celecoxib, lumiracoxib, non-selective NSAIDs, and acetaminophen in osteoarthritis: a mixed treatment comparisonA novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.Lumiracoxib, a highly selective COX-2 inhibitor.Efficacy of celecoxib for pain management after arthroscopic surgery of hip: a prospective randomized placebo-controlled study.The post-operative analgesic efficacy and tolerability of lumiracoxib compared with placebo and naproxen after total knee or hip arthroplasty.Efficacy and safety of PG201 (Layla(®)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study.Analgesics and Antipyretics
P2860
Q26798013-8473429C-9BB0-4699-8DF7-9D6C09E06E95Q28192026-491E8C06-3410-4C38-8634-34328CC314F1Q33323076-1D04C4C8-7123-494B-942F-8293301CA278Q33556721-E157FCCB-50AF-4FED-BF65-3B51E8DDBD27Q34449825-41EAEA50-DC0D-4526-9093-AA4BAC7CE9DBQ34557021-8AE885C2-2694-4A28-877E-32C904A03FABQ34657320-F28255EA-C5B6-4264-A5BB-C31CAA2D9E4DQ34897041-CC0868AC-409B-4147-9173-DE8DFFFFA26BQ35642358-8C715930-9736-4A4C-B794-27184F97AC22Q35925230-721C3F68-47A1-492B-B479-4E7DFFF24B0DQ35961855-1798561D-F4B0-4C9D-BCC6-8C61DC8B412AQ36009834-AC3C28A6-1E6F-47A2-90C6-5B40FC8641B9Q36013803-054E4E67-659F-4DD0-8270-2226B45D3694Q36066121-6EB3C36D-3DCA-4D88-8664-5A492D1BCAEDQ36075955-54BD78D8-0B1A-4C9C-B182-D57883827E87Q36120809-1014EAEE-2D3C-4709-B653-A8B05410E77AQ36471998-9A300750-19CC-4993-81C6-2A1A19E451DDQ36520638-ABAA3F2B-F8D0-4D1D-BA18-00EDE990551CQ36542583-F5E02849-A786-4E02-8C61-E9D3F887D630Q37200568-6C12C93D-664B-4E05-B348-32B41CD08410Q37391095-7D0821B6-E225-4F9B-9CD2-5BEC6065BC15Q37893966-B8AD551D-6E5B-4816-84D5-81246D1EA01AQ38838396-C4F12E82-E9BD-459C-BC82-F253D44D0078Q38993297-064AE13F-670A-4922-AAA2-D6410463B4BBQ41963113-F6A85105-4A99-4477-B7CA-7877583322D8Q42734585-EAE7D065-2834-480E-BDDA-6225BE240FAEQ43061570-6546774F-D522-4C22-B369-E97C0D267148Q45396199-19021FF0-6BB2-4729-B4EA-D2107893D175Q46751386-52F3D981-5056-44AA-A6E2-33CBF87B27FBQ48085671-62BFA47C-6866-426B-A2B1-6C2AE4BB155DQ56113559-E6FAA69C-ABA4-47EB-BD7A-C48DDA4AEF0B
P2860
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Lumiracoxib is effective in th ...... y versus placebo and celecoxib
@ast
Lumiracoxib is effective in th ...... y versus placebo and celecoxib
@en
type
label
Lumiracoxib is effective in th ...... y versus placebo and celecoxib
@ast
Lumiracoxib is effective in th ...... y versus placebo and celecoxib
@en
prefLabel
Lumiracoxib is effective in th ...... y versus placebo and celecoxib
@ast
Lumiracoxib is effective in th ...... y versus placebo and celecoxib
@en
P2093
P2860
P356
P1476
Lumiracoxib is effective in th ...... y versus placebo and celecoxib
@en
P2093
D Uebelhart
F Berenbaum
H Tannenbaum
J Robinson
P2860
P304
P356
10.1136/ARD.2003.015974
P407
P577
2004-02-27T00:00:00Z